Tag: Phase 1 Trial
November 20, 2019
Spring Bank Doses Patients in Phase 1 Clinical Trial of SB 11285
The company announced it has started dosing patients in its Phase 1 clinical trial of SB 11295 in patients with... August 13, 2019
Mustang Bio Announces $9.28 Million Grant to Fund Phase 1 Trial of CAR T Therapy MB-103
Mustang Bio (NASDAQ:MBIO) has announced a US$9.28 million grant from the California Institute for Regenerative Medicine (CIRM) to fund an... April 10, 2019
Concert Pharmaceuticals Initiates Phase 1 Multiple-Ascending Dose Trial of CTP-692
Concert Pharmaceuticals (NASDAQ:CNCE) has started an additional trial in the Phase 1 program evaluating CTP-692, a deuterium-modified form of D-serine... February 11, 2019
Aduro Announces First Patient Dosed in Phase 1 Study of ADU-S100
Aduro Biotech (NASAQ:ADRO) has announced that the first patient has been dosed in a Phase 1 trial of ADU-S100 for... December 3, 2018
Adverum Biotechnologies Announces Publication of Preclinical Long-Term Expression and Efficacy Data in Molecular Therapy
Adverum Biotechnologies (Nasdaq:ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ophthalmology and rare diseases, today announced the... November 19, 2018
Adverum Announces First Patient Dosed in OPTIC Phase 1 Trial of ADVM-022
Adverum Biotechnologies (Nasdaq:ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ophthalmology and rare diseases, today announced that...
November 15, 2018